Scailyte

Biotechnology ResearchSwitzerland11-50 Employees

True precision medicine through single-cell science. 

Scailyte, a pioneer in AI-driven biomarker discovery from single-cell omics data, has leveraged its proprietary AI platform, ScaiVision, to analyze over 60 million single-cell profiles.  The company's extensive network of clinical partners and access to unique patient cohorts in oncology and auto-immunity have led to the development of multiple patent-pending biomarker signatures. Headquartered in Basel, Switzerland, Scailyte collaborates with clinical-stage biotech and pharma companies worldwide, enabling biomarker-driven drug development and paving the way for precision medicine to become a reality.

If you want to partner with, reach out to contact@scailyte.com
 
More information about our company, technology & services you can find on our website - https://scailyte.com

Sign up for free to view info

Email Format Employee directory